CEL-SCI Corporation Depreciation & Amortization 2011-2026 | CVM

Annual Depreciation & Amortization CEL-SCI Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.14 M	2.11 M	1.98 M	447 K	389 K	588 K	575 K	593 K	626 K	680 K	703 K	276 K	447 K	531 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.14 M	276 K	863 K

Quarterly Depreciation & Amortization CEL-SCI Corporation

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
964 K	-	7 K	7 K	995 K	-	7 K	8 K	1 M	-	9 K	10 K	989 K	2.85 M	12 K	13 K	888 K	1.65 M	13 K	13 K	551 K	1.61 M	1.06 M	551 K	503 K	513 K	316 K	503 K	155 K	486 K	308 K	155 K	155 K	476 K	318 K	155 K	159 K	504 K	338 K	159 K	170 K	163 K	50.9 K	41.7 K	56.6 K	173 K	65 K	56.6 K	56.7 K	303 K	79 K	56.7 K	133 K	392 K	112 K	133 K	138 K	373 K	126 K	138 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.85 M	7 K	373 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.9	-0.02 %	$ 6.62 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.46	0.72 %	$ 3.72 B	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Cara Therapeutics CARA	95 K	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	468 K	-	-	$ 35.4 M	USA
ChromaDex Corporation CDXC	612 K	-	-0.88 %	$ 598 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Galectin Therapeutics GALT	1 K	$ 2.37	-0.04 %	$ 151 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.14	1.1 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.67	1.07 %	$ 3.01 B	USA
Heron Therapeutics HRTX	2.31 M	$ 1.19	0.01 %	$ 198 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.45	2.13 %	$ 386 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.98	2.05 %	$ 4.91 M	Israel
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA